Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: A prospective, randomized, double-blind, placebo-controlled, multicenter trial

Journal of Pediatric Surgery

Volumn 48, Issue 1, 2013, Pages 111-117

  El Sawaf, Mohamed ^b   Siddiqui, Sabina ^a   Mahmoud, Moustafa ^b   Drongowski, Robert ^a   Teitelbaum, Daniel H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Aganglionosis; Enterocolitis; Hirschsprung disease; Probiotics

Indexed keywords

PLACEBO; VSL3;

ADULT; AGANGLIONOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG FATALITY; ENTEROCOLITIS; FEEDING DISORDER; FEMALE; FOLLOW UP; HIRSCHSPRUNG ASSOCIATED ENTEROCOLITIS; HIRSCHSPRUNG DISEASE; HUMAN; MALE; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENTEROCOLITIS; FEMALE; FOLLOW-UP STUDIES; HIRSCHSPRUNG DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872401066     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2012.10.028     Document Type: Article

References (26)

1. P. Caneiro, R. Brereton, and D. Drake Enterocolitis in Hirschsprung's disease Pediatr Surg Int 7 1992 356 360
2. E. Elhalaby, A. Coran, and C. Blane Enterocolitis associated with Hirschsprung's disease: a clinical-radiological characterization based on 168 patients J Pediatr Surg 30 1995 76 83
3. D.J. Hackam, R.M. Filler, and R.H. Pearl Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact.[see comment] J Pediatr Surg 33 1998 830 833
4. D. Teitelbaum, S. Qualman, and D. Caniano Hirschsprung's disease. Identification of risk factors for enterocolitis Ann Surg 207 1988 240 244
5. A. Pastor, F. Osman, and D. Teitelbaum Development of a standardized definition for Hirschsprung's-associated enterocolitis: a Delphi analysis J Pediatr Surg 44 2009 251 256
6. B.E. Wildhaber, D.H. Teitelbaum, and A.G. Coran Total colonic Hirschsprung's disease: a 28-year experience J Pediatr Surg 40 2005 203 206 [discussion 206-207]
7. T. Fujimoto Natural history and pathophysiology of enterocolitis in the piebald lethal mouse model of Hirschsprung's disease J Pediatr Surg 23 1988 237 242
8. E.A. Elhalaby, D.H. Teitelbaum, and A.G. Coran Enterocolitis associated with Hirschsprung's disease: a clinical histopathological correlative study J Pediatr Surg 30 1995 1023 1026 [discussion 1026-1027]
9. D.H. Teitelbaum, and A.G. Coran Enterocolitis. [Review] [59 refs] Semin Pediatr Surg 7 1998 162 169
10. C. De Filippo, A. Pini-Prato, and G. Mattioli Genomics approach to the analysis of bacterial communities dynamics in Hirschsprung's disease-associated enterocolitis: a pilot study Pediatr Surg Int 26 2010 465 471
11. A.F. Mattar, A.G. Coran, and D.H. Teitelbaum MUC-2 mucin production in Hirschsprung's disease: possible association with enterocolitis development J Pediatr Surg 38 2003 417 421 [discussion 417-421]
12. M.W. Khan, A.A. Kale, and P. Bere Microbes, intestinal inflammation and probiotics Expert Rev Gastroenterol Hepatol 6 2012 81 94
13. P. Salari, S. Nikfar, and M. Abdollahi A meta-analysis and systematic review on the effect of probiotics in acute diarrhea Inflamm Allergy Drug Targets 11 2012 3 14
14. G. Deshpande, S. Rao, and S. Patole Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates Pediatrics 125 2010 921 930
15. S.D. Holubar, R.R. Cima, and W.J. Sandborn Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis Cochrane Database Syst Rev 2010 CD001176
16. A. Mattar, R. Drongowski, and A.G. Coran MUC-2 mucin production in Hirschsprung's disease: possible association with enterocolitis development J Pediatr Surg 38 3 2003 417 421
17. K.F. Bartizal, C. Salkowski, and J.R. Pleasants The effect of microbial flora, diet, and age on the tumoricidal activity of natural killer cells J Leukoc Biol 36 1984 739 750
18. D.H. Teitelbaum, D.A. Caniano, and S.J. Qualman The pathophysiology of Hirschsprung's-associated enterocolitis: importance of histologic correlates J Pediatr Surg 24 1989 1271 1277
19. D.H. Teitelbaum, R.E. Cilley, and N.J. Sherman A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes Ann Surg 232 2000 372 380
20. D. Wilson-Storey, W. Scobie, and J. Raeburn Defective white blood cell function in Hirschsprung's disease: a possible predisposing factor to enterocolitis J R Coll Surg Edinb 33 1988 185 188
21. D. Wilson-Storey, and W. Scobie Impaired gastrointestinal mucosal defense in Hirschsprung's disease: a clue to the pathogenesis of enterocolitis? J Pediatr Surg 24 1989 462 464
22. D.A. Caniano, D.H. Teitelbaum, and S.J. Qualman The piebald-lethal murine strain: investigation of the cause of early death J Pediatr Surg 24 1989 906 910
23. A. Aslam, R. Spicer, and A. Corfield Children with Hirschsprung's disease have an abnormal colonic mucus defensive barrier independent of the bowel innervation status J Pediatr Surg 32 1997 1206 1210
24. P. Gionchetti, F. Rizzello, and U. Helwig Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Gastroenterology 124 2003 1202 1209
25. B.J. Meijer, and L.A. Dieleman Probiotics in the treatment of human inflammatory bowel diseases: update 2011 J Clin Gastroenterol 45 Suppl 2011 S139 S144
26. S. Dial, J.A. Delaney, and A.N. Barkun Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease JAMA 294 2005 2989 2995